EL7.AI
StocksMediumUpdated•Originally published 28 July 2026•Updated 29 July 2026•
1 min read

Major US Firms Raise Annual Guidance Following Record Q2 Earnings

Key Facts

1Abbott Laboratories, Taiwan Semiconductor, and Johnson & Johnson reported record-breaking Q2 2026 results.
2All three companies raised their full-year financial guidance following strong performance in the earnings cycle.

Amid growing optimism regarding growth sustainability in the industrial, healthcare, and insurance sectors, a new cohort of major corporations has reported strong quarterly results. According to reports, 3M, Travelers, and UnitedHealth have joined the list of companies raising their annual profit forecasts following outsized performance in Q2 2026. This move reinforces the positive momentum established earlier this season by Taiwan Semiconductor, Johnson & Johnson, and Abbott Laboratories.

These upward revisions to financial guidance reflect high operational efficiency and the ability to manage costs within a shifting economic landscape. Per market data, this collective trend of raising annual targets indicates executive confidence in sustained demand through the second half of the year. This performance has been accompanied by notable price stability for these blue-chip stocks, enhancing their appeal as large-cap assets in investor portfolios.

As of the close on July 28, 2026, TSM stood at $391.58 and JNJ at $267.89, while ABT was positioned at $104.49 on July 27, 2026. With markets awaiting further corporate earnings, traders will focus on how MMM, TRV, and UNH shares react to these upgraded outlooks, particularly given the lack of major macroeconomic catalysts in the economic calendar for the next seven days.